Literature DB >> 7014428

A double-blind clinical trial of Arogya-wardhani--an ayurvedic drug--in acute viral hepatitis.

D S Antarkar, A B Vaidya, J C Doshi, A V Athavale, K S Vinchoo, M R Natekar, P S Tathed, V Ramesh, N Kale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7014428

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN： 0971-5916            Impact factor:   2.375


× No keyword cloud information.
  4 in total

Review 1.  The use and safety of non-allopathic Indian medicines.

Authors:  N J Gogtay; H A Bhatt; S S Dalvi; N A Kshirsagar
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Modification of cysteine residue in p65 subunit of nuclear factor-kappaB (NF-kappaB) by picroliv suppresses NF-kappaB-regulated gene products and potentiates apoptosis.

Authors:  Preetha Anand; Ajaikumar B Kunnumakkara; Kuzhuvelil B Harikumar; Kwang Seok Ahn; Vladimir Badmaev; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

3.  Acharya D. S. Antarkar: A Vaidya with a vision.

Authors:  Rama Ashok Vaidya; Ashwinikumar Raut
Journal:  J Ayurveda Integr Med       Date:  2010-01

4.  Implications of traditional medicine in the treatment of Hepatitis A in Kerala.

Authors:  Abin Chandrakumar; Abin Xavier; Augustine Xavier; Anas Manakkadiyil; Anupama Reghu; Levin Thomas
Journal:  J Tradit Complement Med       Date:  2016-03-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.